Alice Levard-Bonneville

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Feasibility and efficacy of MEMMAT-like regimen in heavily pretreated adult patients with recurrent malignant embryonal brain tumors: A series of 6 cases.

Journal: Neuro-oncology advances

Published: June 27, 2025

Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.

Intensive pediatric chemotherapy regimen (PNET HR+5) in adult high-risk medulloblastoma and pineoblastoma patients.

Journal: Neuro-oncology advances

Published: December 02, 2024

Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.

Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.

Journal: Neuro-oncology advances

Published: June 10, 2024

Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT.

Discriminating Inflammatory Radiation-Related Changes From Early Recurrence in Patients With Glioblastomas: A Preliminary Analysis of 68 Ga-PSMA-11 PET/CT Compared With 18 F-FDOPA PET/CT.

Journal: Clinical nuclear medicine

Published: June 05, 2023

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).

Journal: Neuro-oncology

Published: October 21, 2021

MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.

MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.

Journal: Neuro-oncology

Published: April 07, 2021

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.

Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.

Journal: Medical oncology (Northwood, London, England)

Published: December 23, 2020

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer.

Journal: ESMO open

Published: November 01, 2020

Skull vault hemangioma mimicking neoplastic lesion on [68Ga]Ga-PSMA-11 PET/CT in a patient with glioblastoma: A case report.

Skull vault hemangioma mimicking neoplastic lesion on [68Ga]Ga-PSMA-11 PET/CT in a patient with glioblastoma: A case report.

Journal: Radiology case reports

Published: August 28, 2020

Palliative care from the perspective of cancer physicians: a qualitative semistructured interviews study.

Palliative care from the perspective of cancer physicians: a qualitative semistructured interviews study.

Journal: BMJ supportive & palliative care

Published: May 19, 2020

Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.

Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.

Journal: Journal of neuro-oncology

Published: April 21, 2020

Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.

Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: February 14, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026